A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Acta Endocrinologica

• Publication date

  1988-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/ACTA.0.1180374PMID 2455951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.

  1986cited by this paper
• Insulin-like growth factor-binding protein from human plasma. Purification and characterization.

  1986cited by this paper
• Insulin-like growth factors I and II in evaluation of growth retardation.

  1986cited by this paper
• Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.

  1986cited by this paper
• Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats.

  1985cited by this paper
• Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma.

  1985cited by this paper
• Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy.

  1985cited by this paper
• Heterogeneity of rat FSH by chromatofocusing: studies on serum FSH, hormone released in vitro and metabolic clearance rates of its various forms.

  1985cited by this paper
• The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor 1.

  1984cited by this paper
• Factors controlling blood concentration of somatomedin C.

  1984cited by this paper
• Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid.

  1984cited by this paper
• Immunoreactive IGF-II in serum of healthy subjects and patients with growth hormone disturbances and uraemia.

  1984cited by this paper
• Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera.

  1984cited by this paper
• STUDIES OF INSULIN‐LIKE GROWTH FACTOR ‐I AND ‐II BY SPECIFIC RADIOLIGAND ASSAYS IN UMBILICAL CORD BLOOD

  1983cited by this paper
• Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I.

  1983cited by this paper
• A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region.

  1982cited by this paper
• Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

  1981cited by this paper
• Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II.

  1981cited by this paper
• Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum.

  1980cited by this paper
• The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

  1978cited by this paper
• Primary structure of human insulin‐like growth factor II

  1978cited by this paper
• Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein.

  1975cited by this paper
• The use of thyroglobulin to induce antigenicity to small molecules.

  1972cited by this paper
• A method for producing specific antisera with small doses of immunogen.

  1971cited by this paper

• Case 20-2023: A 52-Year-Old Man with a Solitary Fibrous Tumor and Hypoglycemia.

  2023cites this paper
• Concentrations of Insulin-like Growth Factors and Insulin-like Growth Factor-Binding Proteins and Respective Gene Expressions in Children before and after Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Childhood trauma and insulin-like growth factors in amniotic fluid: An exploratory analysis of 79 women.

  2021cites this paper
• Design and fabrication of a smart sensor using in silico epitope mapping and electro-responsive imprinted polymer nanoparticles for determination of insulin levels in human plasma.

  2020cites this paper
• Challenges in endocrinology testing

  2019cites this paper
• Biochemical following-up of treated acromegaly. Limitations of the current determinations of IGF-I and perspective.

  2019cites this paper
• A new p.(Ile66Serfs*93) IGF2 variant is associated with pre- and postnatal growth retardation.

  2019cites this paper
• The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders

  2018cites this paper
• University of Groningen Insulin-like growth factor system in human central nervous system , multiple sclerosis and amyotrophic lateral sclerosis

  2017cites this paper
• The Diagnostic Value of IGF-2 and the IGF/IGFBP-3 System in Silver-Russell Syndrome

  2017cites this paper
• homeostasis in humans Effect of growth hormone on renal and systemic acid-base

  2016cites this paper
• Serum IGF-1 levels measured by different ELISA assays and IRMA – a comparability study

  2015cites this paper
• Protective effects of GM-CSF in experimental neonatal hypothyroidism.

  2015cites this paper
• Paternally Inherited IGF2 Mutation and Growth Restriction.

  2015cites this paper
• Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord

  2015cites this paper
• Determining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards

  2014cites this paper
• The production and regulation of IGF and IGFBPs in human adipose tissue cultures.

  2012cites this paper
• Analytical challenges in the detection of peptide hormones for anti-doping purposes.

  2012cites this paper
• Labordiagnostik bei Wachstumshormon-assoziierten Erkrankungen/Biochemical diagnosis of growth hormone related diseases

  2012cites this paper
• Biochemical diagnosis of growth hormone related diseases

  2012cites this paper
• Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice.

  2011cites this paper
• The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patients

  2010cites this paper
• Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes.

  2009cites this paper
• Fisiologia do eixo GH-sistema IGF

  2008cites this paper
• [Physiology of the GH-IGF axis].

  2008cites this paper
• Das Verhalten von IGF-I und IGFBP-1 und 3 bei kurzdauernder körperlicher Maximalbelastung bei Sportlerinnen im Vergleich zu Nichtsportlerinnen

  2007cites this paper
• Serum Insulin-Like Growth Factor-II (IGF-ll) Levels in Patients with Acromegaly and Growth Hormone Deficiency: Correlation with IGF-l and IGF Binding Protein-3

  2006cites this paper
• IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus.

  2006cites this paper
• Consequences of postnatal insulin-like growth factor II overexpression in insulin-like growth factor I deficient mice

  2005cites this paper
• IGF-I measurements. Epidemiological and clinical aspects.

  2005cites this paper
• The Challenges of Reliance on Insulin-Like Growth Factor I in Monitoring Disease Activity in Patients with Acromegaly

  2005cites this paper
• IGF-I Measurements

  2005cites this paper
• Bedeutung von Insulin-like growth Factor II (IGF-II) und IGF-Bindungsprotein-4 in der Kolonkarzinogenese

  2004cites this paper
• The endocrine consequences for very low birth weight premature infants.

  2004cites this paper
• Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.

  2004cites this paper
• No association between serum levels of insulin‐like growth factor‐I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery

  2004cites this paper
• Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia; evidence for increased muscle glucose uptake

  2004cites this paper
• Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis.

  2004cites this paper
• How Should Insulin-Like Growth Factor I Be Measured?

  2004cites this paper
• Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients.

  2003cites this paper
• Reference Levels of Insulin-Like Growth Factor I in the Serum of Healthy Adults: Comparison of Four Immunoassays

  2003cites this paper
• Insulin-like growth factor system in human central nervous system, multiple sclerosis and amyotrophic lateral sclerosis

  2003cites this paper
• Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.

  2003cites this paper
• Altersabhängigkeit des Insulin-like Growth Factor Systems bei der Wundheilung

  2003cites this paper
• Concentrations of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) in the plasma and milk of pasture-fed dairy cows in early lactation

  2003cites this paper
• Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

  2003cites this paper
• Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment.

  2003cites this paper
• Circulating transforming growth factor beta1 (TGFbeta1) is elevated by extensive exercise.

  2002cites this paper
• Circulating transforming growth factor β1 (TGFβ1) is elevated by extensive exercise

  2002cites this paper
• IGFs and binding proteins in short children with intrauterine growth retardation.

  2002cites this paper
• Determination of Insulin-Like Growth Factor I in Children: Normal Values and Clinical Use

  2001cites this paper
• Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis.

  2001cites this paper
• TGFbeta1 and TGFbeta2 mRNA and protein expression in human bone samples.

  2001cites this paper
• Inhibition of the Insulin-Like Growth Factor (IGF)–IGF-Binding Protein Interaction

  2001cites this paper
• Effects of triiodothyronine on the insulin-like growth factor system in primary human osteoblastic cells in vitro.

  2001cites this paper
• Neuroblastoma: Inhibition of Progression (Part II)

  2001cites this paper
• Analysis of TGFβ3 gene expression and protein levels in human bone and serum

  2001cites this paper
• Diabetes

  2001cites this paper
• Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation.

  2000cites this paper
• Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate

  2000cites this paper
• Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer.

  2000influential citation
• Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.

  2000cites this paper
• Concentrations of insulin-like growth factor (IGF)-I, -II, and IGF binding protein-4, and -5 in human bone cell conditioned medium do not change with age.

  2000cites this paper
• IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes.

  2000cites this paper
• IGF-I- and IGFBP-3-Expression in Cultured Human Preadipocytes and Adipocytes

  2000cites this paper
• A Personal View on the Early History of the Insulin-Like Growth Factors

  1999cites this paper
• Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.

  1999cites this paper
• Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.

  1999cites this paper
• Correlation between cortisol and insulin‐like growth factor‐binding proteins (IGFBPs) under physiological conditions in children

  1999cites this paper
• A personal view on the early history of the insulin-like growth factors.

  1999cites this paper
• Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.

  1999cites this paper
• Determination of Insulin-Like Growth Factor-I in the Monitoring of Growth Hormone Treatment with Respect to Efficacy of Treatment and Side Effects: Should Potential Risks of Cardiovascular Disease and Cancer Be Considered?

  1999cites this paper
• The high molecular weight insulin-like growth factor-binding protein complex: epitope mapping, immunoassay, and preliminary clinical evaluation.

  1999cites this paper
• Insulin-like growth factors and IGF-binding proteins in bovine seminal plasma.

  1999cites this paper
• Workshop: Outcome Measures of GH Therapy

  1999cites this paper
• Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass.

  1999cites this paper
• Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis.

  1998cites this paper
• Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.

  1998cites this paper
• What is the function of IGF-II in postnatal life? Answers from transgenic mouse models.

  1998cites this paper
• Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.

  1998cites this paper
• The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.

  1998influential citation
• Nutritional modulation of canine insulin-like growth factors and their binding proteins.

  1998cites this paper
• Effect of growth hormone on renal and systemic acid-base homeostasis in humans.

  1998cites this paper
• Metabolic effects of adjuvant recombinant human growth hormone in patients with continuing sepsis receiving parenteral nutrition.

  1998cites this paper
• Endurance Training and its Effect upon the Activity of the GH-IGFs System in the Elderly

  1998cites this paper
• Positive association between circulating free thyroxine and insulin‐like growth factor I concentrations in euthyroid elderly individuals

  1998cites this paper
• Effects of growth hormone treatment on serum levels of insulin‐like growth factors (IGFs) and IGF binding proteins 1–4 in postmenopausal women

  1998cites this paper
• Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix.

  1998cites this paper
• A case of Noonan's syndrome with numerous cardiac abnormalities.

  1998cites this paper
• Effect of growth hormone on renal and systemic acid-base homeostasis in humans.

  1998cites this paper
• Increases in insulin-like growth factor binding protein-2 accompany decreases in proliferation and differentiation when porcine muscle satellite cells undergo multiple passages.

  1998cites this paper
• Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.

  1998cites this paper
• High Serum IGFBP-2 in Acute Lymphoblastic Leukemia may be an Indication for Increased Risk of Relapse

  1998cites this paper
• Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice.

  1997cites this paper
• Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone.

  1997cites this paper
• Reduced Concentration of Serum Growth Hormone (GH)-Binding Protein in Children with Chronic Renal Failure: Correlation with GH Insensitivity

  1997cites this paper
• Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans.

  1997cites this paper
• High molecular weight forms of IGF-II ('big-IGF-II') released by Wilms' tumor cells.

  1997cites this paper
• IGF‐I, IGF‐II, free IGF‐I and IGFBP‐1, ‐2 and ‐3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns

  1997cites this paper
• Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children.

  1997cites this paper